Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion

Seoul National University Bundang Hospital160 enrolled

Overview

The aim of this study is to evaluate the success rate, insertion time and complication depending on the use of neuromuscular blocking agent when inserting the laryngeal mask airway (LMA).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

160

Conditions

General Anesthesia Breast Disease

Interventions

use of rocuronium when the LMA is insertedDRUG

Anesthesia is induced with a propofol and remifentanil in both groups, however rocuronium 0.06 mg/kg is injected only in group R. Insertion of LMA is performed by the standard technique according to the manufacturer's instruction. In group N, rocuronium is administered for the operation.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18-70 year * american society of anesthesiologist status 1-2 * elective general anesthesia Exclusion Criteria: * known or predicted difficult airway * recent sore throat * mouth opening less than 2.5 cm * at risk of aspiration

Locations (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Outcomes

Primary Outcomes

success rate and insertion time

Time frame: when laryngeal mask airway is inserted

Secondary Outcomes

complication after the remove of LMA - bleeding, sore throat

Time frame: 1 hour after the LMA is removed

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.